EUVIMEDEUVIMED entdecken
Crossref

Mediastinal Lymphadenopathy as a Prognostic Marker in Acute Pulmonary Embolism

Hans-Jonas Meyer, Mattes Hinnerichs, Anar Aghayev, Daniele Romeo, Yazan Mehsin, Saher Saeed, Jan Borggrefe, Alexey Surov

Journal of Vascular Research · 20.05.2026 · 1-6

DOI: 10.1159/000552631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Research, online erschienen am 20.05.2026. Verfasst von Hans-Jonas Meyer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, University of Leipzig, Leipzig, Germany, jonas90.meyer@web.de. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Computed tomography (CT) is the modality of choice to diagnose acute pulmonary embolism (PE). The present multicentric study aimed to demonstrate the prognostic role of mediastinal lymphadenopathy for short mortality within 30 days in patients with acute PE.

Methods

The investigated patient sample comprised 935 patients (411 female, 44%) with a mean age of 65.3 ± 16.3 years derived from three academic centers. Contrast-enhanced CT pulmonalis angiography was used to assess the presence of mediastinal lymphadenopathy. The primary end point of this study was 30-day mortality. The Simplified Pulmonary Embolism Severity Index (sPESI) was calculated as a clinical prognostic score.

Results

A total of 98 patients (10.5%) died within the 30-day observation period. Mediastinal lymphadenopathy was present in a total of 171 cases (18.3%). Mediastinal lymphadenopathy was associated with 30-day mortality with an odds ratio (OR) of 1.83 (95% confidence interval [CI], 1.12–2.92; p = 0.013 in univariable analysis) and 1.67 (95% CI, 1.01–2.69; p = 0.041 in multivariable analysis).

Conclusion

Mediastinal lymphadenopathy represents an independent prognostic factor for 30-day mortality in patients with acute PE. The underlying pathophysiological mechanisms remain unclear and should be further investigated.

Schlagwörter

Stichwörter der Autor:innen

Computed tomographyLymphadenopathyPulmonary embolism

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, University of Leipzig, Leipzig, Germany, jonas90.meyer@web.de.
  • Department of Radiology and Nuclear Medicine, Otto-von-Guericke University, Magdeburg, Germany.
  • Department of Diagnostic and Interventional Radiology, University of Leipzig, Leipzig, Germany.
  • Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, Palermo, Italy.
  • Institute of Radiology, Neuroradiology and Nuclear Medicine, Johannes-Wesling-Klinikum Minden, Ruhr-University Bochum, Bochum, Germany.

Zitieren

APA

Meyer, H. J., Hinnerichs, M., Aghayev, A., Romeo, D., Mehsin, Y., Saeed, S., Borggrefe, J., & Surov, A. (2026). Mediastinal Lymphadenopathy as a Prognostic Marker in Acute Pulmonary Embolism. Journal of Vascular Research, 1-6. https://doi.org/10.1159/000552631

Vancouver

Meyer HJ, Hinnerichs M, Aghayev A, Romeo D, Mehsin Y, Saeed S, et al. Mediastinal Lymphadenopathy as a Prognostic Marker in Acute Pulmonary Embolism. Journal of Vascular Research. 2026:1-6. doi:10.1159/000552631

BibTeX
@article{Meyer2026,
  author = {Meyer, Hans-Jonas and Hinnerichs, Mattes and Aghayev, Anar and Romeo, Daniele and Mehsin, Yazan and Saeed, Saher and Borggrefe, Jan and Surov, Alexey},
  title = {Mediastinal Lymphadenopathy as a Prognostic Marker in Acute Pulmonary Embolism},
  journal = {Journal of Vascular Research},
  year = {2026},
  pages = {1--6},
  doi = {10.1159/000552631}
}
Kostenlos starten →